SGM_1019



NAME OF DRUG : SGM_1019

ALSO KNOWN AS : SGM_1019

LABORATORY : SecondGenome

STATUS AND ADVANCEMENT

Type of drug : P2X7 inhibitor

Clinical trials advancement : Initiating Phase 2a

Estimated time to market : 122 months.

LABORATORY ABSTRACT ON THE DRUG

NOT PROVIDED

RECENT NEWS ON SGM_1019

SOME PUBLICATIONS RELATED WITH SGM_1019

SOME NASHBIOTECHS POINTS OF VIEW RELATED WITH SGM_1019


WWW.NASHBIOTECHS.COM  -  Copyright G DIVRY 2015-2016  - Contact and TERMS OF USE